$6.26
2.95%
Nasdaq, Apr 21, 08:49 pm CET
ISIN
US89455T1097
Symbol
TMCI

Treace Medical Concepts Inc Stock price

$6.45
-1.52 19.07% 1M
+1.16 21.93% 6M
-0.99 13.31% YTD
-4.95 43.42% 1Y
-12.21 65.43% 3Y
-19.08 74.74% 5Y
-19.08 74.74% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
-0.07 1.07%
ISIN
US89455T1097
Symbol
TMCI
Sector

Key metrics

Market capitalization $405.64m
Enterprise Value $399.61m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.91
P/S ratio (TTM) P/S ratio 1.94
P/B ratio (TTM) P/B ratio 3.56
Revenue growth (TTM) Revenue growth 11.89%
Revenue (TTM) Revenue $209.36m
EBIT (operating result TTM) EBIT $-55.69m
Free Cash Flow (TTM) Free Cash Flow $-48.76m
Cash position $75.68m
EPS (TTM) EPS $-0.90
P/E forward negative
P/S forward 1.78
EV/Sales forward 1.76
Short interest 4.57%
Show more

Is Treace Medical Concepts Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Treace Medical Concepts Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Treace Medical Concepts Inc forecast:

2x Buy
29%
5x Hold
71%

Analyst Opinions

7 Analysts have issued a Treace Medical Concepts Inc forecast:

Buy
29%
Hold
71%

Financial data from Treace Medical Concepts Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
209 209
12% 12%
100%
- Direct Costs 41 41
17% 17%
20%
168 168
11% 11%
80%
- Selling and Administrative Expenses 195 195
8% 8%
93%
- Research and Development Expense 21 21
33% 33%
10%
-47 -47
5% 5%
-23%
- Depreciation and Amortization 8.42 8.42
27% 27%
4%
EBIT (Operating Income) EBIT -56 -56
8% 8%
-27%
Net Profit -56 -56
13% 13%
-27%

In millions USD.

Don't miss a Thing! We will send you all news about Treace Medical Concepts Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Treace Medical Concepts Inc Stock News

Neutral
Business Wire
about 4 hours ago
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming June 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SU...
Neutral
Accesswire
2 days ago
NEW YORK CITY, NY / ACCESS Newswire / April 19, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace Medical To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Treace Medical between May 8, 2023, and May 7, 2024 and would like to discuss your legal rights, call...
Neutral
GlobeNewsWire
5 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Treace Medical To Contact Him Directly To Discuss Their Options
More Treace Medical Concepts Inc News

Company Profile

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Head office United States
CEO John Treace
Employees 477
Founded 2013
Website www.treace.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today